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Abstract
Background:  The human platelet alloantigen system HPA-1 in the Egyptian population was
examined by polymerase chain reaction using sequence-specific primers (PCR-SSP). The objectives
of this study were to evaluate the allele frequency of HPA-1a and -1b in healthy Egyptian individuals
and compare these with the international literature. Human platelet antigen (HPA) systems are
associated with alloimmunization and organ transplantation rejection as well as the development
of cardiovascular disease. Of the various HPA systems, HPA-1 specifically has been considered to
be the most important antigenic system implicated in the Caucasian population. No study has yet
examined this system in the Egyptian populations, however. We therefore investigated the allele
frequency of the HPA-1 system in the Egyptian population.
Findings: To determine the allele frequency of the HPA-1a and -1b, we tested genomic DNAs
from 206 healthy, unrelated Egyptian individuals using PCR-SSP. Our results showed that the 1a/1a
genotype was the most predominant (59.22%) followed by 1a/1b (34.95%) and 1b/1b (5.83%) with
allele frequencies for 1a and 1b of 0.77 and 0.23, respectively, in the population.
Conclusion: As compared with other geographic groups, a relatively high allele frequency of the
HPA-1b in the Egyptian population may indicate a higher risk of alloimmunization. This study is the
first to investigate the allele frequency of the HPA-1 system in the Egyptian population and serves
as an outline for future clinical research associated with platelet disorders in this group.
Background
The human platelet antigens (HPA) systems derive from
the single base pair substitution in the encoding genes of
platelet membrane glycoproteins (GP). The GP variants
resulting from amino acid substitutions are involved in
the rate of alloimmunization to platelet-specific antigens.
Subsequently, the alloimmunization can induce neonatal
alloimmune thrombocytopenia (NAIT) [1], post-transfu-
sion purpura (PTP), or platelet transfusion refractoriness
(PTR) [2]. Therefore, accurate donor compatibility for
platelet transfusions is extremely important. HPA systems
are not only associated with organ transplantation rejec-
tion [3] and cardiovascular disease [4], but are also fre-
quently assessed in general population studies. The
molecular basis of the biallelic polymorphisms of all HPA
systems (i.e. HPA-1, 2, -3, -4, -5, -15) is linked to platelet
GP variants. The major GPs (GPIIb, GPIIIa, GPIb, and
GPIa) generated by single amino acid substitutions are
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associated with various HPAs [5]. The presence of leucine
or proline at position 33 of the GPIIIa results in two HPA-
1a or HPA-1b antigens, respectively [6]. Therefore, molec-
ular DNA-based analysis has been preferred for the HPA
genotyping.
Recent studies of population genetics have reported that
there is a heterogeneous diversity of HPA genotypes in dif-
ferent geographic groups. However, these studies have
largely been performed in Asian, European, and North
American populations [7-9]. Among Arabian popula-
tions, Egyptians are among the most centrally located to
Africa, Europe, and Asia. This fact resulted in Egypt's var-
ied cultural history and its population is a diverse genetic
amalgam. To date, the HPA-1 polymorphisms have not
been assessed in the Egyptian population. The aim of this
study was to investigate the allele frequencies of HPA-1
and estimate the frequency of the 1a and 1b alleles among
the healthy Egyptian population.
Methods
Samples and DNA extraction
Blood samples were collected from 206 unrelated, healthy
Egyptians from Ismailia under institutionally approved
internal review board protocols with informed consent.
DNA was prepared from blood leukocytes by standard
methods [10]. The genotypes of HPA-1 system were deter-
mined using the polymerase chain reaction sequence-spe-
cific primers (PCR-SSP) method designed by Skogen et al.
and the SSPs were used to discriminate between the alleles
encoding the six major HPAs in a series of patients and
normal blood donors [11]. The thermocycler program
consists of an initial step of 94°C for 5 min, followed by
32 cycles of 94°C for 30 s, 65°C for 60 s, 72°C for 60 s,
and a final extension step of 72°C for 10 min. The PCR
products (15 ul) were subjected to gel electrophoresis on
standard 1.5% agarose gel containing 0.5 ug per ml of
ethidium bromide. The typing results were examined
under UV light transillumination. For each sample, it was
possible to determine the absence or presence of the two
alleles, 1a and 1b. Individuals are, therefore, genotypically
classified as 1a/1a, 1a/1b or 1b/1b.
Statistical analysis
Statistical analysis was performed using SPSS version 15
statistical package for windows. Allele and genotype fre-
quencies were calculated by direct counting; Hardy-Wein-
berg equilibrium was assessed by an exact test provided by
the Arlequin program [12].
Results and discussion
The genotype and allele frequencies of HPA-1 system in
the Egyptian population are shown in Table 1. The study
population was found to be in Hardy-Weinberg equilib-
rium. The 1a/1a genotype is the most predominant
(59.22%) followed by 1a/1b (34.95%) and 1b/1b
(5.83%) (Table 1). In these 206 unrelated Egyptian indi-
viduals, the allele frequencies of 1a and 1b were calculated
to be 0.77 and 0.23, respectively. Table 2 describes the
allele frequencies at the HPA-1 with those previously
reported in other ethnic populations.
The allele frequencies of several of HPAs vary among dif-
ferent ethnic groups and their prevalence in a given popu-
lation is a major determinant for the prevalence of HPA
alloimmunization and its clinical associated entities:
NAIT, PTP, PTR, post-transfusion passive alloimmune
thrombocytopenia, and transplantation-associated
alloimmune thrombocytopenia [13]. In one study, HPA-
1 antibodies were found to be present in 80% of patients
with NAIT, and the HPA-1a allele was concluded to be a
factor contributing to the disease [1]. Although alloanti-
bodies against the HPA-1 are frequently implicated in
alloimmunization, the detection of HPA-1 is not recom-
mended in African-American and Asian geographic
groups because of the low allele frequency of the HPA-1b
allele in these populations [8]. As shown in Table 2, the
allele frequency of HPA-1b for the African-American pop-
ulation is in fact lower than that for the Caucasian-Amer-
ican population (0.080 vs. 0.110). Furthermore,
antibodies against HPA-1 antigens were extremely rare in
Japanese patients with NAIT or refractoriness to platelet
transfusion, with an allele frequency of 0.002 for anti-
HPA-1b [14]. Halle et al. recently studied four different
sub-Saharan African populations (Beninese, Camerooni-
Table 1: Distribution of the various HPA-1 genotypes and gene frequencies among the Egyptian population.
HPA-1 Allele Frequency Heterozygosity Frequency Total Chi2 goodness of 
fit test
N HPA-1 Genotype Number Observed 
(Percentage)
1a 1b Observed Expected
206 1a/1a 122 (59.22) 0.767 0.233 0.350 0.357 0.101
(p = 0.7505)
1a/1b 72 (34.95)
1b/1b 12 (5.83)BMC Research Notes 2009, 2:90 http://www.biomedcentral.com/1756-0500/2/90
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ans, Congolese, and Pygmies) and the allele HPA-1b was
reported to be somewhat low by contrast to other HPA
systems (HPA-2, -3, -4, -5, -15) [15]. By contrast, the allele
frequency of HPA-1b in Aka Pygmy populations was
0.000, a result that might explain the low risk of alloim-
munization anti-HPA-1a compared with Caucasian popu-
lations [15].
An increasing number of population genetic studies have
been conducted to assess the effect of the HPA-1 system
on the risk of developing cardiovascular disease or myo-
cardial infarction (MI). However, the data obtained to
date contained contradictions, and the correlation is still
under debate. Weiss et al. reported that HPA-1b increases
the risk of MI or unstable angina in Caucasian popula-
tions [16]. The ratio of developing MI or unstable angina
between patients with the HPA-1a/1a genotype and those
with either the HPA-1a/1b or the 1b/1b genotype was
found to be 6:2 [16]. Other studies highlighted the effect
of HPA-1 in coronary artery disease and showed a positive
correlation in the same age group [17], as well as in the
Caucasian population [18]. By contrast, studies of the Jap-
anese [19] and Korean [20] populations failed to demon-
strate a significant correlation between HPA-1 and the risk
of coronary artery disease or MI. Even in Caucasian popu-
lations, many studies did not detect any relationship [18].
As shown in Table 2, the Egyptians show an HPA-1 allele
frequency that is similar to previously studied Arab popu-
lations (Tunisian, Moroccan, and Bahraini) except for the
Lebanese [21-24]. The Egyptians have a slightly higher fre-
quency of HPA-1b when compared to the Caucasian pop-
ulation (European and White American) [8,25-28]. The
Berbers (Morocco) have been shown to have the highest
frequency for the HPA-1b allele [22]. This is in contrast to
the Asian populations and, in particular, the Amazon
Indian population, which was shown to have total
absence of the HPA-1b allele [29]. The relatively high
allele frequency of the HPA-1b in the Egyptian population
suggests that this ethnic group has a higher risk of alloim-
munization. This is the first to study the allele frequency
of the HPA-1 system in this population and, to date, there
are no data available on the effect of HPA-1 on the risk of
developing alloimmunization, cardiovascular disease, or
MI among Egyptian patients. Although the prevalence of
NAIT, PTP, and PTR has not been established in the Egyp-
tian population yet, the detection of HPA alloantibodies
before any transfusion or pregnancy should be recom-
mended to prevent any clinical condition, especially
when there is a positive family history of cardiovascular
disease. This is because platelet hyperactivity caused by a
conformational change in the GP receptors on the platelet
surface may confer an increased risk for cardiovascular
disease. The authors believe that this study will serve as a
baseline for future clinical research associated with plate-
let disorders or cardiovascular diseases associated with the
Egyptian population.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
AHS designed the research project. AHS performed the
experiments and analyzed data. MAB contributed rea-
gents/materials/analytic tools. KH performed part of the
experimental procedures and helped to draft the manu-
script. AHS and MAB wrote the manuscript. All authors
read and approved the final manuscript.
Acknowledgements
We are grateful to J. A. Walker for her help throughout this project. This 
work was supported by National Science Foundation grant BCS-0218338 
(MAB), and National Institutes of Health RO1 GM59290 (MAB).
References
1. Mueller-Eckhardt C: Post-transfusion purpura.  Br J Haematol
1986, 64:419-424.
2. Borne AE von dem, Decary F: ICSH/ISBT Working Party on
platelet serology. Nomenclature of platelet-specific anti-
gens.  Vox Sang 1990, 58:176.
3. Kekomaki S, Kyllonen L, Salmela K, Koskimies S, Kekomaki R: Plate-
let-specific alloantigens in cadaveric renal transplantation. A
prospective study. Effect of HPA-5b mismatch in acute vas-
cular rejection of renal allografts.  Tissue Antigens 2001,
57:154-157.
4. Ardissino D, Mannucci PM, Merlini PA, Duca F, Fetiveau R, Tagliabue
L, Tubaro M, Galvani M, Ottani F, Ferrario M, et al.: Prothrombotic
genetic risk factors in young survivors of myocardial infarc-
tion.  Blood 1999, 94:46-51.
5. Valentin N, Newman PJ: Human platelet alloantigens.  Curr Opin
Hematol 1994, 1:381-387.
6. Newman PJ, Derbes RS, Aster RH: The human platelet alloanti-
gens, PlA1 and PlA2, are associated with a leucine33/
proline33 amino acid polymorphism in membrane glycopro-
Table 2: Allele frequencies of HPA-1a and -1b in different 
populations.
Population [reference] Allele Frequency (%) N
1a 1b
Berber Moroccan [22] 0.748 0.252 110
Tunisian [23] 0.750 0.250 90
Bahraini [21] 0.760 0.240 194
Egyptian [this study] 0.767 0.233 206
Lebanese [24] 0.810 0.190 205
Danish [28] 0.831 0.169 557
French [26] 0.848 0.152 800
Spanish [27] 0.851 0.149 500
Austrian [7] 0.852 0.148 911
Polish [25] 0.874 0.126 135
Caucasian-American [8] 0.890 0.110 100
African-American [8] 0.920 0.080 100
Korean [9] 0.988 0.012 200
Japanese [14] 0.998 0.002 331
Amazon Indian [29] 1.000 0.000 95Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Research Notes 2009, 2:90 http://www.biomedcentral.com/1756-0500/2/90
Page 4 of 4
(page number not for citation purposes)
tein IIIa, and are distinguishable by DNA typing.  J Clin Invest
1989, 83:1778-1781.
7. Holensteiner A, Walchshofer S, Adler A, Kittl EM, Mayr WR, Panzer
S: Human platelet antigen gene frequencies in the Austrian
population.  Haemostasis 1995, 25:133-136.
8. Kim HO, Jin Y, Kickler TS, Blakemore K, Kwon OH, Bray PF: Gene
frequencies of the five major human platelet antigens in Afri-
can American, white, and Korean populations.  Transfusion
1995, 35:863-867.
9. Seo DH, Park SS, Kim DW, Furihata K, Ueno I, Han KS: Gene fre-
quencies of eight human platelet-specific antigens in Kore-
ans.  Transfus Med 1998, 8:129-132.
10. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A labora-
tory Manual.  Cold Spring Harbor Laboratory Press Cold Spring
Harbor (NY); 1989. 
11. Skogen B, Bellissimo DB, Hessner MJ, Santoso S, Aster RH, Newman
PJ, McFarland JG: Rapid determination of platelet alloantigen
genotypes by polymerase chain reaction using allele-specific
primers.  Transfusion 1994, 34:955-960.
12. Excoffier L, Laval G, Schneider S: Arlequin (version 3.0): An inte-
grated software package for population genetics data analy-
sis.  Evolutionary Bioinformatics Online 2005, 1:47-50.
13. De La Vega Elena CD, Nogues N, Fernandez Montoya A, Chialina S,
Blanzaco PD, Theiller E, Raillon MA, Arancegui N, Solis E, Oyonarte
S, et al.: Human platelet-specific antigens frequencies in the
Argentinean population.  Transfus Med 2008, 18:83-90.
14. Tanaka S, Ohnoki S, Shibata H, Okubo Y, Yamaguchi H, Shibata Y:
Gene frequencies of human platelet antigens on glycopro-
tein IIIa in Japanese.  Transfusion 1996, 36:813-817.
15. Halle L, Bigot A, Mulen-Imandy G, M'Bayo K, Jaeger G, Anani L, Mar-
tageix C, Bianchi F, Julien E, Kaplan C: HPA polymorphism in sub-
Saharan African populations: Beninese, Cameroonians, Con-
golese, and Pygmies.  Tissue Antigens 2005, 65:295-298.
16. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC,
Weiss JL, Gerstenblith G, Goldschmidt-Clermont PJ: A polymor-
phism of a platelet glycoprotein receptor as an inherited risk
factor for coronary thrombosis.  N Engl J Med 1996,
334:1090-1094.
17. Di Castelnuovo A, de Gaetano G, Donati MB, Iacoviello L: Platelet
glycoprotein receptor IIIa polymorphism PLA1/PLA2 and
coronary risk: a meta-analysis.  Thromb Haemost 2001,
85:626-633.
18. Carter AM, Ossei-Gerning N, Grant PJ: Platelet glycoprotein IIIa
PlA polymorphism in young men with myocardial infarction.
Lancet 1996, 348:485-486.
19. Hato T, Minamoto Y, Fukuyama T, Fujita S: Polymorphisms of
HPA-1 through 6 on platelet membrane glycoprotein recep-
tors are not a genetic risk factor for myocardial infarction in
the Japanese population.  Am J Cardiol 1997, 80:1222-1224.
20. Park S, Park HY, Park C, Ko YG, Im EK, Jo I, Shin C, Lee JB, Shim WH,
Cho SY, Jang Y: Association of the gene polymorphisms of
platelet glycoprotein Ia and IIb/IIIa with myocardial infarc-
tion and extent of coronary artery disease in the Korean
population.  Yonsei Med J 2004, 45:428-434.
21. Al-Subaie AM, Al-Absi IK, Al-Ola K, Saidi S, Fawaz NA, Almawi WY:
Gene frequencies of human platelet alloantigens in Bahraini
Arabs.  Am J Hematol 2007, 82:242-244.
22. Ferrer G, Muniz-Diaz E, Aluja MP, Arilla M, Martinez C, Nogues R,
Servin A, Baali A: Analysis of human platelet antigen systems in
a Moroccan Berber population.  Transfus Med 2002, 12:49-54.
23. Mojaat N, Halle L, Proulle V, Hmida S, Ben Hamed L, Boukef K, Kaplan
C: Gene frequencies of human platelet antigens in the Tuni-
sian population.  Tissue Antigens 1999, 54:201-204.
24. Sabbagh AS, Taher AT, Zaatari GS, Mahfouz RA: Gene frequencies
of the HPA-1 platelet antigen alleles in the Lebanese popula-
tion.  Transfus Med 2007, 17:473-478.
25. Drzewek K, Brojer E, Zupanska B: The frequency of human
platelet antigen (HPA) genotypes in the Polish population.
Transfus Med 1998, 8:339-342.
26. Merieux Y, Debost M, Bernaud J, Raffin A, Meyer F, Rigal D: Human
platelet antigen frequencies of platelet donors in the French
population determined by polymerase chain reaction with
sequence-specific primers.  Pathol Biol (Paris) 1997, 45:697-700.
27. Muniz-Diaz E, Arilla M, Ibanez M, Bosch MA, Pastoret C, Madoz P:
[Frequency of platelet alloantigens in the Spanish popula-
tion].  Sangre (Barc) 1993, 38:289-293.
28. Steffensen R, Kaczan E, Varming K, Jersild C: Frequency of plate-
let-specific alloantigens in a Danish population.  Tissue Antigens
1996, 48:93-96.
29. Chiba AK, Bordin JO, Kuwano ST, Figueiredo MS, Carvalho KI, Vieira-
Filho JP, Kerbauy J: Platelet alloantigen frequencies in Amazon
Indians and Brazilian blood donors.  Transfus Med 2000,
10:207-212.